Skip to main content

Advertisement

SpringerLink
Log in

High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer

  • Case Report
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Visceral metastases of breast cancer have been commonly treated with “aggressive” anthracyclines/taxanes-based chemotherapy. In contrast, this case report concerns an elderly patient with advanced breast cancer (pleural effusion, peritoneal carcinosis, and bone metastases) who firmly declined intravenous chemotherapy and was treated for a long time (28 months) with oral vinorelbine. The oral formulation of this drug had activity and a high safety profile, enabling the patient’s wishes to be respected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Romero A, Rabinovich MG, Vallejo CT, Perez JE, Rodriguez R, Cuevas MA, et al. Vinorelbine as first line chemotherapy for metastatic breast carcinoma. J Clin Oncol. 1994;12:336–41.

    PubMed  CAS  Google Scholar 

  2. Vici P, Colucci G, Gebbia V, Amodio A, Giotta F, Belli F, et al. First-line treatment with epirubicin and vinorelbine in metastatic breast cancer. J Clin Oncol. 2002;20:2689–94.

    Article  PubMed  CAS  Google Scholar 

  3. Jassem J, Ramlau R, Karnicka-Mlodkowska H, Krawczyk K, Krzakowski M, Zatloukal P, et al. A multicenter randomized phase II study of oral vs intravenous vinorelbine in advanced non-small-cell lung cancer patients. Ann Oncol. 2001;12:1375–81.

    Article  PubMed  CAS  Google Scholar 

  4. Terenziani M, Demicheli R, Brambilla C, Ferrari L, Moliterni A, Zambetti M, et al. Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study. Breast Cancer Res Treat. 1996;39:285–91.

    Article  PubMed  CAS  Google Scholar 

  5. Freyer G, Delozier T, Lichinister M, Gedouin D, Bougnoux P, His P, et al. Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol. 2003;21:35–40.

    PubMed  CAS  Google Scholar 

  6. Baweja M, Surman VJ, Fitch TR, Mailliard JA, Bernath A, Rawland KM, et al. Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients ≥65 years of age: an NCCTG study. Ann Oncol. 2006;17:623–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Operative Oncology Unit, S. Salvatore Hospital, Pesaro, Italy

    David Rossi, Anna Maria Baldelli, Vincenzo Catalano, Virginia Casadei, Paolo Alessandroni, Paolo Giordani, Francesco Graziano & Stefano Luzi Fedeli

  2. Hematology-Oncology Department, S. Salvatore Hospital, via Lombroso, 61100, Pesaro, Italy

    David Rossi

Authors
  1. David Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Maria Baldelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vincenzo Catalano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Virginia Casadei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paolo Alessandroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paolo Giordani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Francesco Graziano
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Stefano Luzi Fedeli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Rossi.

About this article

Cite this article

Rossi, D., Baldelli, A.M., Catalano, V. et al. High safety profile and activity of oral vinorelbine in an elderly patient with metastatic breast cancer. Breast Cancer 19, 275–277 (2012). https://doi.org/10.1007/s12282-009-0156-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-009-0156-2

Keywords

Search

Navigation